Literature DB >> 11796874

Necrotising fasciitis in a patient receiving infliximab for rheumatoid arthritis.

A T Y Chan1, V Cleeve, T J Daymond.   

Abstract

A case of necrotising fasciitis in a patient receiving infliximab, an antitumour necrosis factor alpha (TNF-alpha) agent for rheumatoid arthritis, is presented. A widespread confluent, erythematous, pustular skin rash was the presenting sign. There was no fever throughout this admission. beta-Haemolytic group A streptococcus was isolated from blood cultures and skin swabs. The adductor muscles and fascia around the site of a previous hip arthroplasty were necrotic on exploration. The case highlights the risk of severe sepsis in patients on anti-TNF-alpha treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11796874      PMCID: PMC1742233          DOI: 10.1136/pmj.78.915.47

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  12 in total

Review 1.  Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.

Authors:  K L Hyrich; A J Silman; K D Watson; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

2.  Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome.

Authors:  Paola Sabrina Buonuomo; Andrea Campana; Antonella Insalaco; Claudia Bracaglia; Manuela Pardeo; Elisabetta Cortis
Journal:  Rheumatol Int       Date:  2011-12-23       Impact factor: 2.631

3.  HIF-1alpha expression regulates the bactericidal capacity of phagocytes.

Authors:  Carole Peyssonnaux; Vivekanand Datta; Thorsten Cramer; Andrew Doedens; Emmanuel A Theodorakis; Richard L Gallo; Nancy Hurtado-Ziola; Victor Nizet; Randall S Johnson
Journal:  J Clin Invest       Date:  2005-07       Impact factor: 14.808

4.  IL-1β is an innate immune sensor of microbial proteolysis.

Authors:  Christopher N LaRock; Jordan Todd; Doris L LaRock; Joshua Olson; Anthony J O'Donoghue; Avril A B Robertson; Matthew A Cooper; Hal M Hoffman; Victor Nizet
Journal:  Sci Immunol       Date:  2016-08-19

Review 5.  [Risk of infection during treatment with tumor necrosis factor-alpha inhibitors].

Authors:  A Gaemperli; T Hauser; R Speck
Journal:  Z Rheumatol       Date:  2006-02       Impact factor: 1.372

6.  Urticaria and angiedema-like skin reactions in a patient treated with adalimumab.

Authors:  S N Nikas; P V Voulgari; A A Drosos
Journal:  Clin Rheumatol       Date:  2006-01-19       Impact factor: 2.980

7.  Fatal group A Streptococcus purpura fulminans in a child receiving TNF-α blocker.

Authors:  Christian Renaud; Philippe Ovetchkine; Patricia Bortolozzi; Claire Saint-Cyr; Bruce Tapiero
Journal:  Eur J Pediatr       Date:  2010-11-10       Impact factor: 3.183

8.  Necrotizing Soft Tissue Infections.

Authors:  Thomas M. File
Journal:  Curr Infect Dis Rep       Date:  2003-10       Impact factor: 3.725

9.  Clinical use of anti-TNF therapy and increased risk of infections.

Authors:  Tauseef Ali; Sindhu Kaitha; Sultan Mahmood; Abdul Ftesi; Jordan Stone; Michael S Bronze
Journal:  Drug Healthc Patient Saf       Date:  2013-03-28

10.  Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis.

Authors:  Kyoung-Hwa Choi; Wan-Hee Yoo
Journal:  Rheumatol Int       Date:  2008-09-16       Impact factor: 3.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.